These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32881369)

  • 1. Dupilumab may facilitate the clearance of molluscum contagiosum in atopic dermatitis patients.
    Di Lernia V; Casanova DM; Simonetti V
    J Dtsch Dermatol Ges; 2020 Sep; 18(9):1016-1018. PubMed ID: 32881369
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab.
    Elosua-González M; Rosell-Díaz Á; Alfageme-Roldán F; Sigüenza-Sanz M; Roustan-Gullón G
    An Bras Dermatol; 2022; 97(3):358-361. PubMed ID: 35307242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis.
    Ferrucci S; Tavecchio S; Veraldi S; Berti E; Benzecry V
    Acta Derm Venereol; 2020 Jul; 100(14):adv00207. PubMed ID: 32556344
    [No Abstract]   [Full Text] [Related]  

  • 4. Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab.
    Storan ER; Woolf RT; Smith CH; Pink AE
    Br J Dermatol; 2019 Aug; 181(2):385-386. PubMed ID: 30719708
    [No Abstract]   [Full Text] [Related]  

  • 5. Hair regrowth and dissemination of molluscum contagiosum: two unexpected effects with dupilumab.
    Sevray M; Dupré D; Misery L; Abasq-Thomas C
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e296-e298. PubMed ID: 30875133
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of widespread molluscum contagiosum caused by baricitinib, a Janus kinase inhibitor.
    Wong GN; Lee S; Foley P
    Australas J Dermatol; 2019 Nov; 60(4):e334-e335. PubMed ID: 31012089
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 8. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 9. Young HIV-positive male patient with severe atopic dermatitis on dupilumab and SARS-CoV-2 infection, a pioneer hypothesis.
    Ordóñez-Rubiano MF; Rubiano-Mojica PC; Casas M
    Int J Dermatol; 2021 Apr; 60(4):514-515. PubMed ID: 33644864
    [No Abstract]   [Full Text] [Related]  

  • 10. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
    Dobkin H; Mullen R; Zirwas M
    Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072
    [No Abstract]   [Full Text] [Related]  

  • 11. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
    Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract]   [Full Text] [Related]  

  • 12. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment.
    Wilson LM; Reid CM
    Australas J Dermatol; 2004 Aug; 45(3):184-5. PubMed ID: 15250900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Dupilumab in an Atopic Adolescent With Primary Immune Deficiency.
    Tanner JF; Knutsen AP; Siegfried E
    Dermatitis; 2021 Oct; 32(1S):e91-e92. PubMed ID: 34677168
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.
    Halling AS; Loft N; Silverberg JI; Guttman-Yassky E; Thyssen JP
    J Am Acad Dermatol; 2021 Jan; 84(1):139-147. PubMed ID: 32822798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series.
    Bosma AL; Gerbens LAA; Middelkamp-Hup MA; Spuls PI
    Clin Exp Dermatol; 2021 Aug; 46(6):1089-1092. PubMed ID: 33969522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 19. Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.
    Paller AS; Green LJ; Silverberg N; Stripling S; Cartwright M; Enloe C; Wells N; Kowalewski EK; Maeda-Chubachi T
    Pediatr Dermatol; 2024; 41(3):438-444. PubMed ID: 38413239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series.
    Amoedo P; Rosa G; Baudrier T; Pedrosa AF; Cruz MJ
    An Bras Dermatol; 2024; 99(5):721-724. PubMed ID: 38834396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.